Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4790 (miR-4790) is a single-stranded, non-coding RNA molecule involved in post-transcriptional regulation of gene expression. Like other microRNAs, it is presumed to regulate gene expression by binding to complementary sequences on target messenger RNAs, resulting in their degradation or suppression of translation[2]. MicroRNAs play essential roles in a wide range of cellular functions, including development, physiology, and disease, by modulating gene expression[2][3]. However, there is little to no information available about miR-4790 specifically in terms of molecular function, disease association, or therapeutic targeting, raising the possibility that it is not a well-characterized or currently validated molecule for biomedical research and therapy. Key details: - MicroRNA 4790 is cataloged as a human microRNA, but its biological function, disease implication, and druggability (therapeutic targeting) are currently uncharacterized in available biomedical literature. - MicroRNAs in general are categorized as "Other" in molecular classification because they are not receptors, enzymes, or other typical drug targets, but non-coding regulatory RNAs[2][3]. - There are no documented drugs, mechanisms of action, or biomarker applications specific to miR-4790. - No specific diseases have been robustly associated with miR-4790, nor is there evidence it is being considered or developed as a direct therapeutic target. Assessment: - microRNA 4790 (miR-4790, hsa-mir-4790, MIR4790) represents a legitimate microRNA gene, but there is insufficient public information regarding its physiological or pathological relevance. - As a result, this entry is marked as is_incorrect: true due to missing information and lack of validation as a therapeutic target or significant biomarker[3]. General information on microRNAs: MicroRNAs are short, single-stranded, non-coding RNAs (about 21–23 nucleotides) found in most multicellular organisms. They regulate gene expression post-transcriptionally, usually by binding to complementary sequences in mRNAs, leading to their destabilization or inhibition[2][3]. While many microRNAs play crucial roles in physiology and disease (including cancer, immunity, and development), not all microRNAs have been extensively studied or linked to disease or therapy[2]. If you require structured data for a canonical microRNA with validated biological or clinical significance, consider using well-characterized examples, as miR-4790 does not currently meet these criteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4790 (miR-4790).